spacer
home > ict > Autumn 2017
PUBLICATIONS

International Clinical Trials

ict
Autumn 2017

   
Text
PDF
Editorís Comment

Dr Graham Hughes
, Editor of ICT, takes a look at some of the key discussion points of this issue, touching on the Internet of Everything, the development of medical devices and the recently instigated EU directives.


 
view
download pdf
bullet
Regulatory & Business Practice
European Focus

Restricting Regulations

Rules and regulations often slowdown clinical trial practices, affecting the processing time between thelaboratory and the consumer. Craig Morgan at goBalto asks whether there is anyopportunity for change in Europe.
 
view
download pdf
bullet
Clinical Trial Management
Mental Health Research

A New Horizon


With mental health often overlooked, Professor Kathryn Abel at NIHR examines new, low-cost methods that could help clinical studies in this particular field.
 
view
download pdf
Managing Cell and Gene Therapies

Perfect Planning


As the worldwide market for regenerative medicines continues to grow, Lisa Vocat at World Courier talks about the logistical challenges now faced when developing new drugs for this therapeutic area.

 
view
download pdf
Trials in Pneumonia

Problematic Patterns


The team at PSI CRO discuss how distinguishing trends followed by serious adverse effects is vital when large amounts of new antibiotics are being tested for community acquired pneumonia.

 
view
download pdf
Unifying Operations

Better Together


Rik Van Mol at Veeva Systems believes the answer to questions surrounding streamlining clinical systems is industry-wide operational continuity.
 
view
download pdf
bullet
Drug delivery & Therapeutics
Serialisation Beyond Compliance

Keeping Track

Serialisation is an essential factor in maintaining compliance, but Steve Wood at Covectra notes its potential in other areas, such as anti-counterfeiting and delivery to end-users.

 
view
download pdf

Patient Recruitment and Retention
Mobile Services

Closer to Home


The incorporation of mobile units within patient recruitment can improve retention and enrolment rates. Lindsey Copeland and Diane Campbell at CK Aspire discuss the impact this has on clinical trials.
 
view
download pdf
Translation and Local Knowledge

In Other Words

Gary Muddyman at Conversis analyses the complex undertaking of communicating messages to a global audience, highlighting the importance of tailoring your content and ensuring quality of data.
 
view
download pdf

Interview
Q&A: Adapting to New Regulations

Hindering Hazards


Patrick Hughes at CluePoints explains the impact of new regulatory updates in trial quality maintenance, specifically covering ICH E6 R2, and how pharma companies can handle this shift.
 
view
download pdf
bullet
Digital Advances
IoE in Clinical Trails

Superior Strategy

CRF Healthís Richard Strobridge reflects on how the Internet of Everything could positively impact healthcare in terms of improved patient experience and focus within clinical trials.
 
view
download pdf
Wearable Technology

Fastening Pharmaceuticals


Jeremy Wheeler at Quanticate reviews the noticeable benefits that incorporating wearable medical devices may have or pharma companies trying to bring new medicines to the market.

 
view
download pdf
New Developments in Patient Outcomes

Technological Takeover


IBM Watson Healthís Jeff Beeler and Alysa Lesemann consider how patient-reported outcomes, alongside new technological reporting methods, can provide guidance
when developing new drugs.

 
view
download pdf
Compliant Packaging

Handle with Care


The shipping of biological substances across borders needs to be rigorously regulated, so Sue Fletcher at Alpha Laboratories Ltd discusses the importance of complying with UN3373.
 
view
download pdf
End Point

A Costly Cause

Looking to the future of clinical trials, ICT editor Dr Graham Hughes emphasises the worrisome impact of the expensive development of precision medicines.

 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Volga-Dnepr And Scan Global Logistics Support Ongoing Health Programs In Turkmenistan

Under UN agency vaccination program Volga-Dnepr Group and Scan Global Logistics collaborated and worked together to deliver 180 cbm of vaccines and medical supplies to Turkmenistan. The cargo contained vital Diphteria/Hepatitis and BCG vaccine doses as well as clinical/medical supplies. Amid COVID-19 pandemic the ongoing immunization programs have become particularly important.
More info >>

White Papers

Advantages of Quantitative NMR for the Determination of Relative Response Factors

Novatia, LLC

Quantitative NMR (qNMR) is a technique that is being applied broadly and at an increasing rate in the field of pharmaceutical analysis (1). This white paper highlights the advantages of using qNMR to determine Relative Response Factors (RRFs) for pharmaceutical impurities detectable by HPLC. A single determination of RRFs using qNMR allows for simple and accurate quantitation of impurities which eliminates the need for preparation, qualification, and storage of reference standards. An example is presented here, which demonstrates quantitation of known impurities that have variable responses to UV-VIS detection, thereby providing a more accurate assessment of impurity levels than UV-VIS response alone.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement